An Open-Label Study of INV-1120 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Advanced Solid Tumors

NCT04443088 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

78

Enrollment

INDUSTRY

Sponsor class

Conditions

Cancer
Solid Tumor, Adult
Cancer Metastatic
Solid Carcinoma
Solid Tumor, Unspecified, Adult
Tumor, Solid

Interventions

DRUG: INV-1120
COMBINATION_PRODUCT: Pembrolizumab

Sponsor

Shenzhen Ionova Life Sciences Co., Ltd.

Collaborators

[object Object]